Navicixizumab
HY-P99377
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameNavicixizumab
- Delivery Days Customer10
- CertificationResearch Use Only
- Scientific DescriptionNavicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer[1][2][3].
- UNSPSC12352203